TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2014

Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.

Satoshi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.